Insight Molecular Diagnostics Inc. (IMDX) Gross margin 2020–2025
Insight Molecular Diagnostics Inc. (IMDX) gross margin by fiscal year — reported gross profit divided by reported revenue.
56.7%FY2025 · since FY2020: -52.5% → 56.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 56.7% | +17.3 pp |
| FY2024 | 39.3% | +11.9 pp |
| FY2023 | 27.5% | +29.4 pp |
| FY2022 | -1.9% | -66.5 pp |
| FY2021 | 64.6% | +117.2 pp |
| FY2020 | -52.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice